Search results for "Nocturia"

showing 10 items of 17 documents

Factors associated with nocturia-related quality of life in men with lower urinary tract symptoms and treated with tamsulosin oral controlled absorpt…

2020

Nocturia impairs quality of life (QoL). We have performed a non-interventional study in which men with lower urinary tract symptoms (LUTS) were treated for at least 3 months with tamsulosin oral controlled absorption system (0.4 mg q.d.). Other than observing efficacy and tolerability of this drug formulation, the study was designed to explore the relative roles of number of nocturia episodes and of non-urological causes of nocturia on nocturia-related QoL at baseline and treatment-associated changes thereof. The study enrolled 5775 men seeking treatment of their LUTS. Tamsulosin improved LUTS, e.g. International Prostate Symptom Score from 19.5 +/- 5.9 to 10.1 +/- 4.9 (means +/- SD). This …

0301 basic medicinemedicine.medical_specialtyurologic and male genital diseases03 medical and health sciences0302 clinical medicineQuality of lifeLower urinary tract symptomsTamsulosinInternal medicinemedicineNocturiaPharmacology (medical)Original ResearchPharmacologyHeart Failurebusiness.industrylcsh:RM1-950DiabetesSleep apneamedicine.diseasehumanitiesfemale genital diseases and pregnancy complications030104 developmental biologylcsh:Therapeutics. PharmacologyTolerability030220 oncology & carcinogenesisHeart failureQuality of LifeInternational Prostate Symptom ScoreNocturiamedicine.symptombusinessMale Lower Urinary Tract Symptomsmedicine.drug
researchProduct

Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study

2007

Objectives: To investigate efficacy, safety, and impact on quality of sleep of desmopressin in the treatment of nocturia. Methods: Adults aged >= 18 yr with nocturia (>= 2 voids/night) received desmopressin tablets (0.1, 0.2, or 0.4 mg) during a 3-wk dose-titration period. Patients should show sufficient response during the dose-titration period (>= 20% reduction in nocturnal diuresis) and a return of nocturnal diuresis to >= 80% of baseline levels during washout. Eligible patients then entered a 3-wk double-blind treatment period and received either desmopressin or placebo. Results: 127 patients were randomised to either desmopressin (n = 61) or placebo (n = 66). Twenty (33%) desmopressin-…

AdultMaleNephrologymedicine.medical_specialtyUrologyPlacebo-controlled studyAdministration OralDiuresisPlaceboDouble-Blind MethodInternal medicinemedicineHumansNocturiaDeamino Arginine VasopressinDesmopressinAdverse effectAgedAged 80 and overDose-Response Relationship Drugbusiness.industryAntidiuretic AgentsMiddle AgedSurgeryUrodynamicsTreatment OutcomeAnesthesiaFemaleNocturiamedicine.symptomSleepbusinesshormones hormone substitutes and hormone antagonistsFollow-Up Studiesmedicine.drugAntidiureticEuropean Urology
researchProduct

Sleep-wake disturbances in patients with amyotrophic lateral sclerosis

2011

Objective To evaluate the frequency, severity and determinants of sleep disturbances in patients with amyotrophic lateral sclerosis (ALS). Methods Information about night-time complaints was collected using a standardised questionnaire, the Pittsburgh Sleep Quality Index (PSQI), and the Epworth Sleepiness Scale (ESS) in a group of 100 patients with ALS and in 100 control subjects matched for age and sex. Functional disability was assessed using the ALS Functional Rating Scale-Revised (ALSFRS-R). Sleep was studied by overnight polysomnography in 12 patients. Results Fifty-nine patients with ALS and 36 controls reported sleep disturbances. The mean global PSQI score of patients with ALS was s…

AdultMaleSleep Wake Disordersmedicine.medical_specialtyNeuromuscular diseasePolysomnographyPolysomnographySeverity of Illness IndexPittsburgh Sleep Quality IndexSurveys and QuestionnairesmedicineHumansNocturiaamyotrophic lateral sclerosis sleep disordersWakefulnessAmyotrophic lateral sclerosisDepression (differential diagnoses)Agedmedicine.diagnostic_testEpworth Sleepiness ScaleAmyotrophic Lateral SclerosisMiddle Agedmedicine.diseaseSleep in non-human animalsPsychiatry and Mental healthCase-Control StudiesPhysical therapyFemaleSurgeryNeurology (clinical)medicine.symptomSleepPsychologyJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Trends and Prevalence of Nocturia Among US Adults, 2005-2016

2019

Purpose: Increased nocturia episodes can be a clinical marker of poor health status. The present study aimed to evaluate patterns and temporal trends in nocturia and sociodemographic and lifestyle correlates in the US population. Methods: Participants, aged 20 years or older, were included in this repeated cross-sectional study. The National Health and Nutrition Examination Survey from 2005 to 2016 was used. Participants were asked “During the past 30 days, how many times per night did you most typically get up to urinate, from the time you went to bed at night until the time you got up in the morning?”. Individuals were categorized as either ≥ 1 nocturia episode or ≥ 2 nocturia episodes pe…

AdultMaleTime FactorsNational Health and Nutrition Examination SurveyUrologymedia_common.quotation_subjectPopulation030232 urology & nephrologyClinical marker030204 cardiovascular system & hematologyUrination03 medical and health sciencesYoung AdultSoysal P. Cao C. Xu T. Yang L. Isik A. Turan K. Liu Q. Pizzol D. Veronese N. Demurtas J. et al. -Trends and prevalence of nocturia among US adults 2005-2016.- International urology and nephrology 20190302 clinical medicineAge groupsPrevalenceMedicineNocturiaHumanseducationNocturia · Trend · United States · NHANESMorningmedia_commoneducation.field_of_studybusiness.industryMiddle AgedUnited StatesSecular variationCross-Sectional StudiesNephrologyFemaleNocturiamedicine.symptombusinessDemography
researchProduct

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC st…

2006

Abstract Objective Estimate the prevalence of urinary incontinence (UI), overactive bladder (OAB), and other lower urinary tract symptoms (LUTS) among men and women in five countries using the 2002 International Continence Society (ICS) definitions. Methods This population-based, cross-sectional survey was conducted between April and December 2005 in Canada, Germany, Italy, Sweden, and the United Kingdom using computer-assisted telephone interviews. A random sample of men and women aged ≥ 18 yr residing in the five countries and who were representative of the general populations in these countries was selected. Using 2002 ICS definitions, the prevalence estimates of storage, voiding, and po…

AdultMalemedicine.medical_specialtyCanadaAdolescentCross-sectional studyUrologyPopulationUrinary incontinenceSeverity of Illness IndexAge DistributionLower urinary tract symptomsGermanymedicinePrevalenceNocturiaHumansSex DistributioneducationAgedRetrospective StudiesGynecologySwedeneducation.field_of_studybusiness.industryUrinary Bladder OveractiveMiddle Agedmedicine.diseaseThe Overactive Bladder QuestionnaireUnited KingdomUrodynamicsCross-Sectional StudiesUrinary IncontinenceOveractive bladderItalyPopulation SurveillanceCohortFemalemedicine.symptombusinessDemographyEuropean urology
researchProduct

Effect of Six-Month Diet Intervention on Sleep among Overweight and Obese Men with Chronic Insomnia Symptoms : A Randomized Controlled Trial

2016

Growing evidence suggests that diet alteration affects sleep, but this has not yet been studied in adults with insomnia symptoms. We aimed to determine the effect of a six-month diet intervention on sleep among overweight and obese (Body mass index, BMI >= 25 kg/m(2)) men with chronic insomnia symptoms. Forty-nine men aged 30-65 years with chronic insomnia symptoms were randomized into diet (n = 28) or control (n = 21) groups. The diet group underwent a six-month individualized diet intervention with three face-to-face counseling sessions and online supervision 1-3 times per week; 300-500 kcal/day less energy intake and optimized nutrient composition were recommended. Controls were instruct…

CounselingMaleobesityTime FactorsINTERNATIONAL CLASSIFICATIONOverweightinsomnia symptomsBody Mass Indexlaw.invention0302 clinical medicineRandomized controlled triallawSleep Initiation and Maintenance DisordersSurveys and QuestionnairesInsomniasleep onset030212 general & internal medicineFinlandPOPULATION2. Zero hungerdiet interventionNutrition and Dieteticsylipainota3141Middle AgedWEIGHT-GAINPREVALENCE3. Good healthTreatment OutcomeBALANCESleep diarymedicine.symptomSleep onsetNutritive Valuelcsh:Nutrition. Foods and food supplyAdultmedicine.medical_specialtyDiet ReducingNutritional Statuslcsh:TX341-641Articleuni (lepotila)DISORDERS ICSD03 medical and health sciencesInternal medicineWeight LossReaction TimemedicineHumansQUALITYNocturiaoverweightsleepAgedCaloric Restrictionbusiness.industrynutrientENERGY-EXPENDITUREinsomnia symptoms; sleep; sleep onset; diet intervention; nutrient; overweight; obesity3141 Health care scienceNutrition AssessmentFATRISK-FACTORSPhysical therapylihavuusSleep onset latencybusinessWeight gain030217 neurology & neurosurgeryFood ScienceNutrients
researchProduct

Sleep Quality in Patients with Heart Failure in the Spanish Population: A Cross-Sectional Study

2020

Background: Heart failure is a major problem in western societies. Sleep Disorders maintain a bidirectional relationship with heart failure, as shown by studies conducted in other countries. This study aims to describe the quality of sleep in Spanish patients with heart failure. Materials and methods: We carried out a cross-sectional study to analyze the quality of sleep in a sample of 203 patients with a diagnosis of heart failure admitted to an Internal Medicine Service. The Pittsburg Sleep Quality Index (PSQI) was used to evaluate sleep quality in our sample over a one-month period. Results: 75% of the sample presented sleep disorders. The most common problems included the interruption o…

MaleSleep Wake Disordersmedicine.medical_specialtyCross-sectional studyHealth Toxicology and Mutagenesisheart failurelcsh:Medicine030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesMedicineNocturiaHumans030212 general & internal medicineAgedsleep disorderAged 80 and overSleep disorderSleep qualitybusiness.industryBrief Reportlcsh:RPublic Health Environmental and Occupational Healthsleep qualitymedicine.diseaseSleep in non-human animalsSpanish populationCross-Sectional StudiesSpainHeart failureEmergency medicineBreathingFemaleheart failure sleep disorder sleep qualitymedicine.symptombusinessSleepInternational Journal of Environmental Research and Public Health
researchProduct

A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis

2012

Abstract Context Nocturia is a common urologic symptom that has been covered in a variety of reported studies in the literature but is not specifically covered in current guidelines. Objective To comprehensively review the literature pertaining to the definition, etiologies, and consequences of nocturia and assess the evidence supporting the use of conservative medical and interventional therapy. Evidence acquisition A literature search was conducted using the keyword nocturia , restricted to articles in the English language, after 2000 and before April 2012, in PubMed/Medline, Embase, Scopus, Web of Science, and Cochrane Library databases. Regarding treatment modalities, studies were inclu…

MaledesmopressinPathologyAnti-Inflammatory AgentsCochrane Libraryurologic and male genital diseaseslaw.inventionsystematic reviewRandomized controlled trialRisk FactorslawEpidemiologyOdds RatioPrevalencea1-blockersDesmopressina1-blockers; alpha(1)-blockers; antimuscarinics; desmopressin; meta-analysis; nocturia; nocturnal polyuria; systematic review; α1-blockersEvidence-Based MedicineAntidiuretic AgentsDiagnostic Techniques UrologicalMiddle AgedPathophysiologyfemale genital diseases and pregnancy complicationsTreatment OutcomeMeta-analysisUrologic Surgical ProceduresFemaleNocturiaα1-blockersmedicine.symptommedicine.drugmedicine.medical_specialtyUrologyMEDLINEMuscarinic Antagonistsalpha(1)-blockersPredictive Value of TestsInternal medicinemedicineHumansNocturiaIntensive care medicineantimuscarinicsAgedChi-Square Distributionbusiness.industrynocturnal polyuriaEvidence-based medicinemeta-analysisClinical trialUrodynamicsEndocrinologyAdrenergic alpha-1 Receptor AntagonistsbusinessEuropean urology
researchProduct

EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.

2013

To present a summary of the 2013 version of the European Association of Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms (LUTS). We conducted a literature search in computer databases for relevant articles published between 1966 and 31 October 2012. The Oxford classification system (2001) was used to determine the level of evidence for each article and to assign the grade of recommendation for each treatment modality. Men with mild symptoms are suitable for watchful waiting. All men with bothersome LUTS should be offered lifestyle advice prior to or concurrent with any treatment. Men with bothersome moderate-to-severe LUTS quickly benefit from α1-blocke…

Malemedicine.medical_specialtyPhosphodiesterase Inhibitorsmedicine.medical_treatmentUrologyUrologyProstatic HyperplasiaMuscarinic AntagonistsSeverity of Illness Indexchemistry.chemical_compound5-alpha Reductase InhibitorsLower Urinary Tract SymptomsLower urinary tract symptomsmedicineNocturiaHumansWatchful WaitingTransurethral resection of the prostateUrinary retentionProstatectomybusiness.industryTransurethral Resection of Prostatemedicine.diseaseDutasterideTreatment OutcomechemistryAdrenergic alpha-1 Receptor AntagonistsUrological AgentsProstate surgeryStentsmedicine.symptombusinessUrinary CatheterizationRisk Reduction BehaviorWatchful waitingEuropean urology
researchProduct

Does concomitant diabetes affect treatment responses in overactive bladder patients?

2013

Summary Aims To compare the efficacy and tolerability of a muscarinic receptor antagonist, darifenacin, in the treatment of overactive bladder (OAB) patients with concomitant diabetes as compared with those without comorbidities. Methods Post hoc exploratory analysis of a published, large, non-interventional study in OAB patients treated with darifenacin including 532 diabetics and 1315 controls. Associations of diabetes with treatment responses were evaluated by multiple regression models. Results Diabetics (largely type 2 patients) and controls differed in baseline age, body weight, duration of OAB symptoms and presence of comedications. However, they exhibited similar OAB symptom episode…

Malemedicine.medical_specialtyPyrrolidinesMuscarinic Antagonistsurologic and male genital diseasesAffect (psychology)Diabetes ComplicationsDiabetes mellitusInternal medicineMuscarinic acetylcholine receptorDarifenacinMedicineHumansBenzofuransDose-Response Relationship Drugbusiness.industryUrinary Bladder OveractiveAntagonistUrinary Bladder DiseasesGeneral MedicineMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsEndocrinologyTreatment OutcomeUrinary IncontinenceTolerabilityOveractive bladderConcomitantRegression AnalysisFemaleNocturiabusinessmedicine.drugInternational journal of clinical practice
researchProduct